Currently predicting for Tue, 28 May 2024

Trading levels for XERS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.00 3.65 %
R2 1.98 2.35 %
R1 1.96 1.55 %
Current price: 1.93
Support S1 1.91 -1.05 %
S2 1.89 -1.86 %
S3 1.87 -3.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.21 14.51 %
R2 2.13 10.36 %
R1 1.98 2.59 %
Current price 1.93
Support S1 1.78 -7.77%
S2 1.76 -8.81%
S3 1.75 -9.33%

XERS Predictions History

3 years ago
ZZZAAA predicted that XERS for 2021-05-24 is going

Rank:

3 years ago
JS predicted that XERS for 2020-12-21 is going $4.57 (-11.61%)

3 years ago
MubasharAli predicted that XERS for 2020-12-21 is going

Rank:

3 years ago
Alan predicted that XERS for 2020-12-21 is going $4.82 (3.88%)

3 years ago
JS predicted that XERS for 2020-12-02 is going $4.31 (3.11%)

3 years ago
Bill Elliott predicted that XERS for 2020-12-02 is going

Rank:

3 years ago
JS predicted that XERS for 2020-10-19 is going $5.02 (-1.18%)

3 years ago
iHustle84 predicted that XERS for 2020-10-19 is going $4.76 (-6.30%)

3 years ago
Brian160563 predicted that XERS for 2020-10-19 is going

Rank:

3 years ago
JS predicted that XERS for 2020-08-28 is going $3.66 (-13.88%)

Click to get the best stock tips daily for free!

About Xeris Pharmaceuticals Inc

Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi... XERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT